Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OncoGeneX Technologies Inc.

This article was originally published in Start Up

Executive Summary

OncoGeneX Technologies was founded specifically to develop OGX-011, a compound that inhibits the production of clusterin, a cell survival protein found to be up-regulated in many cancers after exposure to standard cancer therapies including chemotherapy, radiation therapy, and hormone ablation.

You may also be interested in...



PhageTech Inc.

PhageTech is mining the genome of phage virus, which infect bacteria, for targets with which to create a new generation of antibiotics.

Thios Pharmaceuticals Inc.

Sulfation is the process in which sulfate recovered by cells from the bloodstream is attached to target molecules, such as glycoproteins. Thios Pharmaceuticals, formed around its founders' sulfation research, believes these pathways will be fertile ground for identifying a new class of therapeutic targets.

Cyclis Pharmaceuticals Inc.

Normally during the cell cycle, molecular signaling checkpoints prevent cell division in the event of chromosomal shuffling or DNA damage. Cyclis Pharmaceuticals is developing cancer drugs that turn on the deactivated cellular surveillance system, leading to apoptosis and cell death.

Topics

Related Companies

Related Deals

UsernamePublicRestriction

Register

SC090638

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel